Eyepoint Net Working Capital from 2010 to 2025

EYPT Stock  USD 6.27  0.36  5.43%   
Eyepoint Pharmaceuticals Net Working Capital yearly trend continues to be comparatively stable with very little volatility. Net Working Capital is likely to outpace its year average in 2025. From the period from 2010 to 2025, Eyepoint Pharmaceuticals Net Working Capital quarterly data regression had r-value of  0.83 and coefficient of variation of  131.40. View All Fundamentals
 
Net Working Capital  
First Reported
2020-03-31
Previous Quarter
219.8 M
Current Value
334.3 M
Quarterly Volatility
85.6 M
 
Covid
Check Eyepoint Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyepoint Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 13.3 K or Total Revenue of 45.4 M, as well as many indicators such as Price To Sales Ratio of 9.21, Dividend Yield of 0.0 or PTB Ratio of 1.18. Eyepoint financial statements analysis is a perfect complement when working with Eyepoint Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Eyepoint Pharmaceuticals Correlation against competitors.
For more information on how to buy Eyepoint Stock please use our How to Invest in Eyepoint Pharmaceuticals guide.

Latest Eyepoint Pharmaceuticals' Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Eyepoint Pharmaceuticals over the last few years. It is Eyepoint Pharmaceuticals' Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eyepoint Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Eyepoint Net Working Capital Regression Statistics

Arithmetic Mean95,821,494
Geometric Mean39,586,808
Coefficient Of Variation131.40
Mean Deviation105,002,054
Median30,197,000
Standard Deviation125,905,738
Sample Variance15852.3T
Range338.5M
R-Value0.83
Mean Square Error5152.8T
R-Squared0.70
Significance0.000058
Slope22,072,374
Total Sum of Squares237783.8T

Eyepoint Net Working Capital History

2025351 M
2024334.3 M
2023281.5 M
2022138.3 M
2021214.1 M
202048.2 M

About Eyepoint Pharmaceuticals Financial Statements

Eyepoint Pharmaceuticals shareholders use historical fundamental indicators, such as Net Working Capital, to determine how well the company is positioned to perform in the future. Although Eyepoint Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Eyepoint Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Eyepoint Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Working Capital334.3 M351 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eyepoint Stock Analysis

When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.